Global and North America Opioid-induced Constipation Market Status and Future Forecast 2013-2023

May 2018 | 95 pages | ID: G3BC9597F47EN
99Strategy

Abstracts

SUMMARY

Key Content of Chapters (Including and can be customized)

Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Region
Part 3:
North America Market by company, Type, Application & Region
Part 4-6:
Key Regions of North America Market by Type, Application
Part 7:
Company information, Sales, Cost, Margin etc.
Part 8:
Conclusion

Market Segment as follows:

By Region

• Global (North America, Europe, Asia etc.)
• North America (United States, Canada, Mexico)

Key Companies

• AstraZeneca
• Takeda Pharmaceutical
• Valeant Pharmaceuticals International
• Abbott
• Bayer
• Boehringer Ingelheim
• C.B. Fleet
• Cosmo Pharmaceuticals
• Daewoong
• Daiichi Sankyo
• GlaxoSmithKline
• Ironwood Pharmaceuticals
• Johnson & Johnson
• Merck
• Mundipharma
• Nektar Therapeutics
• Pfizer
• Progenics Pharmaceuticals
• Shionogi
• SLA Pharma
• Sucampo
• Synergy Pharmaceuticals
• Theravance

Market by Type

• Solid
• Liquid

Market by Application

• Drugstore
• Hospital
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

3.1 North America Market by Region
3.2 North America Market by Company
3.3 North America Market by Type
3.4 North America Market by Application
3.5 North America Market by Forecast

PART 4 UNITED STATES MARKET STATUS AND FUTURE FORECAST

4.1 United States Market by Type
4.2 United States Market by Application
4.3 United States Market by Forecast

PART 5 CANADA MARKET STATUS AND FUTURE FORECAST

5.1 Canada Market by Type
5.2 Canada Market by Application
5.3 Canada Market by Forecast

PART 6 MEXICO MARKET STATUS AND FUTURE FORECAST

6.1 Mexico Market by Type
6.2 Mexico Market by Application
6.3 Mexico Market by Forecast

PART 7 KEY COMPANIES

7.1 AstraZeneca
7.2 Takeda Pharmaceutical
7.3 Valeant Pharmaceuticals International
7.4 Abbott
7.5 Bayer
7.6 Boehringer Ingelheim
7.7 C.B. Fleet
7.8 Cosmo Pharmaceuticals
7.9 Daewoong
7.10 Daiichi Sankyo
7.11 GlaxoSmithKline
7.12 Ironwood Pharmaceuticals
7.13 Johnson & Johnson
7.14 Merck
7.15 Mundipharma
7.16 Nektar Therapeutics
7.17 Pfizer
7.18 Progenics Pharmaceuticals
7.19 Shionogi
7.20 SLA Pharma
7.21 Sucampo
7.22 Synergy Pharmaceuticals
7.23 Theravance

PART 8 CONCLUSION

List Of Tables

LIST OF TABLES

Table Type of Opioid-induced Constipation
Table Application of Opioid-induced Constipation
Table Global Opioid-induced Constipation Market by Region, 2013-2017 (Million USD)
Table Global Opioid-induced Constipation Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table Global Opioid-induced Constipation Market by Company, 2013-2017 (Million USD)
Table Global Opioid-induced Constipation Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table Global Opioid-induced Constipation Market by Type, 2013-2017 (Million USD)
Table Global Opioid-induced Constipation Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Global Opioid-induced Constipation Market by Application, 2013-2017 (Million USD)
Table Global Opioid-induced Constipation Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table North America Opioid-induced Constipation Market by Region, 2013-2017 (Million USD)
Table North America Opioid-induced Constipation Market by Region, 2013-2017 (Volume)
Table Price List by Region, 2013-2017
Table North America Opioid-induced Constipation Market by Company, 2013-2017 (Million USD)
Table North America Opioid-induced Constipation Market by Company, 2013-2017 (Volume)
Table Price List by Company, 2013-2017
Table North America Opioid-induced Constipation Market by Type, 2013-2017 (Million USD)
Table North America Opioid-induced Constipation Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table North America Opioid-induced Constipation Market by Application, 2013-2017 (Million USD)
Table North America Opioid-induced Constipation Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table United States Opioid-induced Constipation Market by Type, 2013-2017 (Million USD)
Table United States Opioid-induced Constipation Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table United States Opioid-induced Constipation Market by Application, 2013-2017 (Million USD)
Table United States Opioid-induced Constipation Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Canada Opioid-induced Constipation Market by Type, 2013-2017 (Million USD)
Table Canada Opioid-induced Constipation Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Canada Opioid-induced Constipation Market by Application, 2013-2017 (Million USD)
Table Canada Opioid-induced Constipation Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table Mexico Opioid-induced Constipation Market by Type, 2013-2017 (Million USD)
Table Mexico Opioid-induced Constipation Market by Type, 2013-2017 (Volume)
Table Price List by Type, 2013-2017
Table Mexico Opioid-induced Constipation Market by Application, 2013-2017 (Million USD)
Table Mexico Opioid-induced Constipation Market by Application, 2013-2017 (Volume)
Table Price List by Application, 2013-2017
Table AstraZeneca Information
Table Opioid-induced Constipation Sales, Cost, Margin of AstraZeneca
Table Takeda Pharmaceutical Information
Table Opioid-induced Constipation Sales, Cost, Margin of Takeda Pharmaceutical
Table Valeant Pharmaceuticals International Information
Table Opioid-induced Constipation Sales, Cost, Margin of Valeant Pharmaceuticals International
Table Abbott Information
Table Opioid-induced Constipation Sales, Cost, Margin of Abbott
Table Bayer Information
Table Opioid-induced Constipation Sales, Cost, Margin of Bayer
Table Boehringer Ingelheim Information
Table Opioid-induced Constipation Sales, Cost, Margin of Boehringer Ingelheim
Table C.B. Fleet Information
Table Opioid-induced Constipation Sales, Cost, Margin of C.B. Fleet
Table Cosmo Pharmaceuticals Information
Table Opioid-induced Constipation Sales, Cost, Margin of Cosmo Pharmaceuticals
Table Daewoong Information
Table Opioid-induced Constipation Sales, Cost, Margin of Daewoong
Table Daiichi Sankyo Information
Table Opioid-induced Constipation Sales, Cost, Margin of Daiichi Sankyo
Table GlaxoSmithKline Information
Table Opioid-induced Constipation Sales, Cost, Margin of GlaxoSmithKline
Table Ironwood Pharmaceuticals Information
Table Opioid-induced Constipation Sales, Cost, Margin of Ironwood Pharmaceuticals
Table Johnson & Johnson Information
Table Opioid-induced Constipation Sales, Cost, Margin of Johnson & Johnson
Table Merck Information
Table Opioid-induced Constipation Sales, Cost, Margin of Merck
Table Mundipharma Information
Table Opioid-induced Constipation Sales, Cost, Margin of Mundipharma
Table Nektar Therapeutics Information
Table Opioid-induced Constipation Sales, Cost, Margin of Nektar Therapeutics
Table Pfizer Information
Table Opioid-induced Constipation Sales, Cost, Margin of Pfizer
Table Progenics Pharmaceuticals Information
Table Opioid-induced Constipation Sales, Cost, Margin of Progenics Pharmaceuticals
Table Shionogi Information
Table Opioid-induced Constipation Sales, Cost, Margin of Shionogi
Table SLA Pharma Information
Table Opioid-induced Constipation Sales, Cost, Margin of SLA Pharma
Table Sucampo Information
Table Opioid-induced Constipation Sales, Cost, Margin of Sucampo
Table Synergy Pharmaceuticals Information
Table Opioid-induced Constipation Sales, Cost, Margin of Synergy Pharmaceuticals
Table Theravance Information
Table Opioid-induced Constipation Sales, Cost, Margin of Theravance

List Of Figures

LIST OF FIGURES

Figure Global Opioid-induced Constipation Market Share by Type in 2018
Figure Global Opioid-induced Constipation Market Share by Application in 2018
Figure Global Opioid-induced Constipation Market Share by Region in 2018
Figure North America Opioid-induced Constipation Market Share by Region in 2018
Figure Global Opioid-induced Constipation Market Share by Region in 2017 (Million USD)
Figure Global Opioid-induced Constipation Market Share by Region in 2017 (Volume)
Figure Global Opioid-induced Constipation Market Share by Company in 2017 (Million USD)
Figure Global Opioid-induced Constipation Market Share by Company in 2017 (Volume)
Figure Global Opioid-induced Constipation Market Share by Type in 2017 (Million USD)
Figure Global Opioid-induced Constipation Market Share by Type in 2017 (Volume)
Figure Global Opioid-induced Constipation Market Share by Application in 2017 (Million USD)
Figure Global Opioid-induced Constipation Market Share by Application in 2017 (Volume)
Figure Global Opioid-induced Constipation Market Forecast, 2018-2023 (Million USD)
Figure Global Opioid-induced Constipation Market Forecast, 2018-2023 (Volume)
Figure North America Opioid-induced Constipation Market Share by Region in 2017 (Million USD)
Figure North America Opioid-induced Constipation Market Share by Region in 2017 (Volume)
Figure North America Opioid-induced Constipation Market Share by Company in 2017 (Million USD)
Figure North America Opioid-induced Constipation Market Share by Company in 2017 (Volume)
Figure North America Opioid-induced Constipation Market Share by Type in 2017 (Million USD)
Figure North America Opioid-induced Constipation Market Share by Type in 2017 (Volume)
Figure North America Opioid-induced Constipation Market Share by Application in 2017 (Million USD)
Figure North America Opioid-induced Constipation Market Share by Application in 2017 (Volume)
Figure North America Opioid-induced Constipation Market Forecast, 2018-2023 (Million USD)
Figure North America Opioid-induced Constipation Market Forecast, 2018-2023 (Volume)
Figure United States Opioid-induced Constipation Market Share by Type in 2017 (Million USD)
Figure United States Opioid-induced Constipation Market Share by Type in 2017 (Volume)
Figure United States Opioid-induced Constipation Market Share by Application in 2017 (Million USD)
Figure United States Opioid-induced Constipation Market Share by Application in 2017 (Volume)
Figure United States Opioid-induced Constipation Market Forecast, 2018-2023 (Million USD)
Figure United States Opioid-induced Constipation Market Forecast, 2018-2023 (Volume)
Figure Canada Opioid-induced Constipation Market Share by Type in 2017 (Million USD)
Figure Canada Opioid-induced Constipation Market Share by Type in 2017 (Volume)
Figure Canada Opioid-induced Constipation Market Share by Application in 2017 (Million USD)
Figure Canada Opioid-induced Constipation Market Share by Application in 2017 (Volume)
Figure Canada Opioid-induced Constipation Market Forecast, 2018-2023 (Million USD)
Figure Canada Opioid-induced Constipation Market Forecast, 2018-2023 (Volume)
Figure Mexico Opioid-induced Constipation Market Share by Type in 2017 (Million USD)
Figure Mexico Opioid-induced Constipation Market Share by Type in 2017 (Volume)
Figure Mexico Opioid-induced Constipation Market Share by Application in 2017 (Million USD)
Figure Mexico Opioid-induced Constipation Market Share by Application in 2017 (Volume)
Figure Mexico Opioid-induced Constipation Market Forecast, 2018-2023 (Million USD)
Figure Mexico Opioid-induced Constipation Market Forecast, 2018-2023 (Volume)